NCT00766818View on ClinicalTrials.gov

The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
PregnancyHIV
Interventions
DRUG

Kaletra

Kaletra 400/100mg BID, then increase at 30weeks to 500/125mg BID

Trial Locations (1)

27599

University of North Carolina, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT00766818 - The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet | Biotech Hunter | Biotech Hunter